Bioptik Technology Incorporation (TPEX:4161)

Market Cap	1.37B -20.6%
Revenue (ttm)	837.19M -3.3%
Net Income	71.19M -23.9%
EPS	1.21 -23.9%
Shares Out	59.81M
PE Ratio	18.93
Forward PE	n/a
Dividend	0.70 (3.06%)
Ex-Dividend Date	n/a

Volume	207,063
Average Volume	148,169
Open	23.20
Previous Close	23.40
Day's Range	22.90 - 23.20
52-Week Range	22.90 - 30.50
Beta	0.27
RSI	34.09
Earnings Date	May 15, 2026

About TPEX:4161

Bioptik Technology Incorporation engages in the manufacturing, wholesale, and retail of biotechnology and medical equipment in Taiwan and internationally. The company offers blood glucose, cholesterol, uric acid, hemoglobin and acid multi-function monitoring systems under the EasyMate, EasySure, and EasyTouch brand name, as well as PeTouch, a glucose monitoring system for dogs and cats. It also provides dietary supplements, such as capsules, gel capsules, tablets, solutions, powder sachet, jelly, and gummy; cosmetic products, including sunscree...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4161

Financial Performance

In 2025, TPEX:4161's revenue was 837.19 million, a decrease of -3.25% compared to the previous year's 865.34 million. Earnings were 71.19 million, a decrease of -23.92%.